首页> 美国卫生研究院文献>other >Use of Tissue Microarray and Automated Quantitative Analysis For Screening and Validation of Potential Biomarkers in Mantle Cell Lymphoma

【2h】

Use of Tissue Microarray and Automated Quantitative Analysis For Screening and Validation of Potential Biomarkers in Mantle Cell Lymphoma

机译：利用组织芯片和自动定量分析在套细胞淋巴瘤潜在生物标志物的筛选和验证

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundCancer biomarker studies utilizing the combination of tissue microarray and automated quantitative assessment of immunofluorescence (TMA-AQUA) have been successfully performed for various types of human carcinoma, but its performance characteristics have yet to be evaluated in human lymphoma.

著录项

期刊名称 other
作者
David T. Yang; Philip J. Quann; Adam M. Petrich; Catherine P. Leith; Ken H. Young; Brad S. Kahl;
展开▼
作者单位

展开▼
年(卷),期 -1(19),1
年度 -1
页码 62–69
总页数 12
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Use of tissue microarray and automated quantitative analysis for screening and validation of potential biomarkers in mantle cell lymphoma. [J] . Yang DT, Quann PJ, Petrich AM, Applied immunohistochemistry and molecular morphology: AIMM . 2011,第1期

机译：使用组织芯片和自动定量分析筛选和验证套细胞淋巴瘤中潜在的生物标志物。
2. Immunohistochemical Prognostic Markers In Diffuse Large B-cell Lymphoma: Validation Of Tissue Microarray As A Prerequisite For Broad Clinical Applications (a Study From The Lunenburg Lymphoma Biomarker Consortium) [J] . D de Jong, W Xie, A Rosenwald, Journal of Clinical Pathology . 2009,第2期

机译：弥漫性大型B细胞淋巴瘤中的免疫组织化学预后标志物：组织芯片的验证作为广泛临床应用的前提（Lunenburg淋巴瘤生物标志物联盟的一项研究）
3. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium. [J] . de-Jong D, Rosenwald A, Chhanabhai M, Journal of Clinical Oncology . 2007,第7期

机译：弥漫性大B细胞淋巴瘤中的免疫组织化学预后标志物：验证组织微阵列作为广泛临床应用的先决条件-来自Lunenburg淋巴瘤生物标志物联盟的一项研究。
4. Quantitative mass spectrometry for proteomic screening of potential biomarkers in Alzheimer's disease [C] . Sravani Musunuri, Kim Kultima, Martin Ingelsson, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2013

机译：阿尔茨海默病潜在生物标志物蛋白质组学筛选的定量质谱
5. SERS-Based Detection and Quantification of Cancer Biomarkers in Cells and Tissue Microarrays [D] . Bhamidipati, Manjari 2018

机译：基于SERS的细胞和组织微阵列中癌症生物标志物的检测和定量
6. Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3 as potential predictors of response to R-CHOP [O] . Rita Coutinho, Andrew J. Clear, Emanuele Mazzola, 2015

机译：使用组织芯片和免疫组织化学研究弥漫性大B细胞淋巴瘤的免疫微环境：可靠的半自动化分析显示CD3和FoxP3可作为对R-CHOP反应的潜在预测因子
7. Use of Tissue Microarray and Automated Quantitative Analysis for Screening and Validation of Potential Biomarkers in Mantle Cell Lymphoma [O] . David T. Yang, Philip J. Quann, Adam M. Petrich, 2011

机译：组织微阵列的使用和自动定量分析筛网淋巴瘤潜在生物标志物的筛选和验证

Use of Tissue Microarray and Automated Quantitative Analysis For Screening and Validation of Potential Biomarkers in Mantle Cell Lymphoma

摘要

著录项

相似文献

相关主题

期刊订阅